About this event:

Date: September 15, 2022

Time: 11 am EDT | 8 am PDT |
5 pm CET

Duration: 30 minutes

As demand for viral vectors has grown in recent years, larger production scales are increasingly common. As processes scale, transient transfection must also scale to match. The VirusGEN^® family of transfection products, developed by Mirus Bio, has been used successfully at scale in clinical manufacturing and brings unique advantages leading to higher titers and a more robust manufacturing process.

In this webinar we will discuss:

• Challenges and solutions for transfection at manufacturing scale, including the transfection complex formation step.
• The advantages of VirusGEN^® in optimizing a transfection workflow.
• How VirusGEN^® GMP AAV and LV products enable higher titers and more robust manufacturing processes.